Alopecia areata

Hair, Hair Growth and Hair Disorders

Volumn , Issue , 2008, Pages 311-332

  Freyschmidt Paul, Pia ^a   Hoffmann, Rolf ^b   McElwee, Kevin J ^c  

^a University of British Columbia ^*  (Germany)

^b NONE   (Germany)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892335125     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-46911-7_15     Document Type: Chapter

References (96)

1. Abell E, Munro DD (1973) Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector. Br J Dermatol 88:55-59.
2. Alsaleh QA, Nanda A, al-Hasawi F, el-Kashlan M (1995) Concurrent appearance of alopecia areata in siblings. Pediatr Dermatol 12:285-286.
3. Averbakh EV, Pospelov LE (1986) HLA antigens in patients with alopecia areata. Vestn Dermatol Venerol 1:24-26.
4. Barahmani N, de Andrade M, Slusser JP, Zhang Q, Duvic M (2006) Major histocompatibility complex class I chain-related gene A polymorphisms and extended haplotypes are associated with familial alopecia areata. J Invest Dermatol 126(1):74-78.
5. Betterle C, Greggio NA, Volpato M (1998) Clinical review 93. Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 83:1049-1055.
6. Blaumeiser B, van der Goot I, Fimmers R, Hanneken S, Ritzmann S, Seymons K, Betz RC, Ruzicka T, Wienker TF, De Weert J, Lambert J, Kruse R, Nothen MM (2006) Familial aggregation of alopecia areata. J Am Acad Dermatol 54(4):627-632.
7. Bystryn J-C, Tamesis J (1991) Immunological aspects of hair loss. J Invest Dermatol 96:88s-89s.
8. Carroll JM, McElwee KJ, King L, Byrne MC, Sundberg JP (2002) Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans. J Invest Dermatol 119:392-402.
9. Carter DM, Jegasothy BV (1976) Alopecia areata and Down syndrome. Arch Dermatol 112:1397-1399.
10. Case PC, Mitchell AJ, Swanson NA, Vanderveen EE, Ellis CN, Headington JT (1984) Topical therapy of alopecia areata with squaric acid dibutylester. J Am Acad Dermatol 10:447-451.
11. Caserio RJ (1987) Treatment of alopecia areata with squaric acid dibutylester. Arch Dermatol 123:1036-1041.
12. Colombe BW, Price VH, Khoury EL, Garovoy MR, Lou CD (1995) HLA class II antigen associations help to define two types of alopecia areata. J Am Acad Dermatol 33:757-64.
13. Colon EA, Popkin MK, Callies AL, Dessert NJ, Hordinsky MK (1991) Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Compr Psychiatry 32:245-251.
14. Cork MJ, Crane AM, Duff GW (1996) Genetic control of cytokines: cytokine gene polymorphisms in alopecia areata. Dermatol Clin 14:671-678.
15. Cotellessa C, Peris K, Caracciolo E, Mordenti C, Chimenti S (2001) The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata. J Am Acad Dermatol 44:73-76.
16. Du Vivier A, Munro DD (1975) Alopecia areata, autoimmunity, and Down's syndrome. Br Med J I:191-192.
17. Duvic M, Hordinsky MK, Fiedler VC, O'Brien WR, Young R, Reveille JD (1991) HLA-D locus associations in alopecia areata. Arch Dermatol 127:64-68.
18. Eggefagh L, Neorost S, Mirmirani P (2004) Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicle. Arch Dermatol 140: 1012.
19. Elenkov IJ, Chrousos GP (2002) Stress hormones, proinflammatory and anti-inflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 966:290-303.
20. Frentz G (1977) Topical treatment of extended alopecia. Dermatologica 155:147-154.
21. Freyschmidt-Paul P, Hoffmann R, Levine E, Sundberg JP, Happle R, McElwee KJ (2001) Current and potential agents for the treatment of alopecia areata. Curr Pharm Des 7:213-230.
22. Freyschmidt-Paul P, Happle R, McElwee KJ, Hoffmann R (2003) Alopecia areata: Treatment today and potential treatments of tomorrow. J Invest Dermatol Symp Proc 8:12-17.
23. Freyschmidt-Paul P, McElwee K, Hoffmann R (2005) Alopecia areata. In: Hertl M (ed) Autoimmune diseases of the skin: pathogenesis, diagnosis, management. Springer, Berlin Heidelberg New York, pp 385-420.
24. Fulop E, Vajda Z (1971) Experimentelle Untersuchungen uber die therapeutische und schadigende Wirkung der intrafokalen Steroidbehandlung. Dermatol Monatsschr 157:269-277.
25. Galbraith GM, Pandey JP (1989) Km1 allotype association with one subgroup of alopecia areata. Am J Hum Genet 44:426-428.
26. Galbraith GM, Pandey JP (1995) Tumor necrosis factor alpha (TNF-Alpha) gene polymorphism in alopecia areata. Hum Genet 96:433-436.
27. Galbraith GM, Thiers BH, Pandey JP (1984) Gm allotype associated resistance and susceptibility to alopecia areata. Clin Exp Immunol 56:149-152.
28. Galbraith GM, Palesch Y, Gore EA, Pandey JP (1999) Contribution of interleukin 1beta and KM loci to alopecia areata. Hum Hered 49:85-89.
29. Gilhar A, Pillar T, Assay B, David M (1992) Failure of passive transfer of serum from patients with alopecia areata and alopecia universalis to inhibit hair growth in transplants of human scalp skin grafted on to nude mice. Br J Dermatol 126:166-171.
30. Gilhar A, Landau M, Assy B, Shalaginov R, Serafimovich S, Kalish RS (2002) Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: Transfer to human scalp explants on Prkdc(scid) mice. Arch Dermatol 138:916-922.
31. Goldsmith LA (1991) Summary of alopecia areata research workshop and future research directions. J Invest Dermatol 96:98S-100S.
32. Gordon PM, Aldridge RD, McVittie E, Hunter JAA (1996) Topical diphencyprone for alopecia areata: Evaluation of 48 cases after 30 months' follow up. Br J Dermatol 134:869-871.
33. Gundogan C, Greve B, Raulin C (2004) Treatment of alopecia areata with the 308-nm xenon chloride excimer laser: case report of two successful treatments with the excimer laser. Lasers Surg Med 34:86-90.
34. Happle R, Kalveram KJ, Buchner U, Echternacht-Happle K, Goggelmann W, Summer KH (1980) Contact allergy as a therapeutic tool for alopecia areata: Application of squaric acid dibutylester. Dermatologica 161:289-297.
35. Happle R, Hausen BM, Wiesner-Menzel L (1983) Diphencyprone in the treatment of alopecia areata. Acta Derm Venereol (Stockh) 63:49-52.
36. Happle R, Perret C, Wiesner-Menzel L (1984) Treatment of alopecia areata with diphencyprone induces hair regrowth and affects the composition of peribulbar infiltrates. In: MacDonald DM (ed) Immunodermatology. Butterworth, London, pp 279-86.
37. Herbst V, Zoller M, Kissling S, Wenzel E, Stutz N, Freyschmidt- Paul P (2006) Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes. Eur J Dermatol 15(5):537-542.
38. Hordinsky MK, Hallgren H, Nelson D, Filipovich AH (1984) Familial alopecia areata. HLA antigens and autoantibody formation in an American family. Arch Dermatol 120:464-468.
39. Hoting E, Boehm A (1992) Therapy of alopecia areata with diphencyprone. Br J Dermatol 127:625-629.
40. Kalkoff KW, Macher E (1958) Uber das Nachwachsen der Haare bei der Alopecia areata und maligna nach intracutaner Hydrocortisoninjektion. Hautarzt 9:441-451.
41. Kurosawa M, Nakagawa S, Mizuashi M, Sasaki Y, Kawamura M, Saito M, Aiba S (2006) A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata. Dermatology 212:361-365.
42. Liakopoulou M, Alifieraki T, Katideniou A, Kakourou T, Tselalidou E, Tsiantis J, Stratigos J (1997) Children with alopecia areata: psychiatric symptomatology and life events. J Am Acad Child Adolesc Psychiatry 36:678-684.
43. Lu W, Shapiro J, Yu M, Barekatain A, Lo B, Finner A, McElwee K (2006) Alopecia areata: pathogenesis and potential for therapy. Expert Rev Mol Med 8:1-19.
44. Macdonald Hull S, Cunliffe WJ (1991) Successful treatment of alopecia areata using the contact allergen diphencyprone. Br J Dermatol 124:212-213.
45. Macdonald Hull S, Norris JF (1988) Diphencyprone in the treatment of long-standing alopecia areata. Br J Dermatol 119:367-374.
46. Macdonald Hull S, Pepall L, Cunliffe WJ (1991) Alopecia areata in children: Response to treatment with diphencyprone. Br J Dermatol 125:164-168.
47. MacDonald Hull SP, Wood ML, Hutchinson PE, Sladden M, Messenger AG (2003) Guidelines for the management of alopecia areata. Br J Dermatol 149:692-699.
48. McElwee KJ, Boggess D, King LE Jr, Sundberg JP (1998) Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-Thickness skin grafts. J Invest Dermatol 111:797-803.
49. McElwee KJ, Boggess D, Olivry T, Oliver RF, Whiting D, Tobin DJ, Bystryn JC, King LE Jr, Sundberg JP (1998) Comparison of alopecia areata in human and nonhuman mammalian species. Pathobiology 66:90-107.
50. McElwee KJ, Bristol IJ, Boggess D, Leiter EH, King LE Jr, Elson CO, Cong Y, Sundberg JP (1999) A common disease susceptibility gene locus for development of alopecia areata and/or colitis in C3H/HeJ mice. J Invest Dermatol Symp Proc 4:249.
51. McElwee KJ, Tobin DJ, Bystryn JC, King LE Jr, Sundberg JP (1999) Alopecia areata: An autoimmune disease? Exp Dermatol 8:371-379.
52. McElwee K, Freyschmidt-Paul P, Ziegler A, Happle R, Hoffmann R (2001) Genetic susceptibility and severity of alopecia areata in human and animal models. Eur J Dermatol 11:11-16.
53. McElwee KJ, Silva K, Beamer WG, King LE Jr, Sundberg JP (2001) Melanocyte and gonad activity as potential severity modifying factors in C3H/HeJ mouse alopecia areata. Exp Dermatol 10:420-429.
54. McElwee KJ, Freyschmidt-Paul P, Zoller M, Hoffmann R (2003) Alopecia areata susceptibility in rodent models. J Investig Dermatol Symp Proc 8:182-187.
55. McElwee KJ, Niiyama S, Freyschmidt-Paul P, Wenzel E, Kissling S, Sundberg JP, Hoffmann R (2003) Dietary soy oil content and soy-derived phytoestrogen genistein increase resistance to alopecia areata onset in C3H/HeJ mice. Exp Dermatol 12:30-36.
56. McElwee KJ, Freyschmidt-Paul P, Hoffmann R, Kissling S, Hummel S, Vitacolonna M, Zoller M (2005) Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(-) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse model. J Invest Dermatol 124:947-957.
57. McElwee KJ, Yu M, Park SW, Ross EK, Finner A, Shapiro J (2005) What can we learn from animal models of Alopecia areata? Dermatology 211:47-53.
58. Micali G, Cicero RL, Nasca MR, Sapuppo A (1996) Treatment of alopecia areata with squaric acid dibutylester. Int J Dermatol 35:52-56.
59. Michie HJ, Jahoda CA, Oliver RF, Johnson BE (1991) The DEBR rat: An animal model of human alopecia areata. Br J Dermatol 125:94-100.
60. Mo J, Zlotogorski A, Martinez-Mir A, Duvic M, Hordinsky M, Norris D, Price V, Nanova K, Gilliam TC, Londono D, Gordon D, Christiano AM (2007) A genomewide scan maps a first susceptibility locus for alopecia areata to human chromosome 6q23.3 (in press).
61. Monk B (1989) Induction of hair growth in alopecia totalis with diphencyprone sensitization. Clin Exp Dermtol 14:154-157.
62. Morling N, Frentz G, Fugger L, Georgsen J, Jakobsen B, Odum N, Svejgaard A (1991) DNA polymorphism of HLA class II genes in alopecia areata. Dis Markers 9:35-42.
63. Muller SA, Winkelmann RK (1963) Alopecia areata: An evaluation of 736 patients. Arch Dermatol 88:290-297.
64. Ochsendorf FR, Mitrou G, Milbradt R (1988) Therapie der Alopecia Areata mit Diphenylcyclopropenone. Z Hautkr 63:94-100.
65. Orentreich N, Sturm HM, Weidman AI, Pelzig A (1960) Local injection of steroids and hair regrowth in alopecias. Arch Dermatol 82:894-902.
66. Paus R (1996) Control of the hair cycle and hair diseases as cycling disorders. Curr Opin Dermatol 3:248-258.
67. Paus R, Nickoloff BJ, Ito T (2005) A "hairy" privilege. Trends Immunol 26:32-40.
68. Pforr J, Blaumeiser B, Becker T, Freudenberg-Hua Y, Hanneken S, Eigelshoven S, Cuyt I, De Weert J, Lambert J, Kruse R, Nothen MM, Betz RC (2006) Investigation of the p.Ser278Arg polymorphism of the autoimmune regulator (AIRE) gene in alopecia areata. Tissue Antigens 68(1):58-61.
69. Porter D, Burton JL (1971) A comparison of intra-lesional triamcinolone hexacetonide and triamcinolone acetonide in alopecia areata. Br J Dermatol 85:272.
70. Price V, Hordinsky M, Leonardi C, Roberts J, Olsen E, Rafal E, Korman N, Leung H, Garovoy M, Caro I, Whiting D (2006) Safety and efficacy results of a clinical study of efalizumab in patients with alopecia areata. J Invest Dermatol 126:105.
71. Puavilai S, Puavilai G, Charuwichitratana S, Sakuntabhai A, Sriprachya-Anunt S (1994) Prevalence of thyroid diseases in patients with alopecia areata. Int J Dermatol 33:632-633.
72. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd (1995) Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 70:628-633.
73. Schuttelaar M-LA, Hamstra JJ, Plinck EP, Peereboom- Wynia JDR, Vuzevski VD, Mulder PGH, Oranje AP (1996) Alopecia areata in children: Treatment with diphencyprone. Br J Dermatol 135:581-585.
74. Seiter S, Ugurel S, Tilgen W, Reinhold U (2001) Dermatology. High-dose pulse corticosteroid therapy in the treatment of severe alopecia areata. Dermatology 202:230-234.
75. Seyrafi H, Akhiani M, Abbasi H, Mirpour S, Gholamrezanezhad A (2005) Evaluation of the profile of alopecia areata and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients. BMC Dermatol 31:5:11.
76. Sharma VK, Kumar B, Dawn G (1996) A clinical study of childhood alopecia areata in Chandigarh, India. Pediatr Dermatol 13:372-377.
77. Shellow WV, Edwards JE, Koo JY (1992) Profile of alopecia areata: A questionnaire analysis of patient and family. Int J Dermatol 31:186-189.
78. Stankler L (1979). Synchronous alopecia areata in two siblings: A possible viral aetiology. Lancet 1:1303-1304.
79. Steen van der PHM, Baar van JMJ, Perret C, Happle R (1991) Treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol 24:253-257.
80. Sundberg JP, Boggess D, Silva KA, McElwee KJ, King LE, Li R, Churchill G, Cox GA (2003) Major locus on mouse chromosome 17 and minor locus on chromosome 9 are linked with alopecia areata in C3H/HeJ mice. J Invest Dermatol 120(5):771-775.
81. Tan E, Tay YK, Goh CL, Chin Giam Y (2002). The pattern and profile of alopecia areata in Singapore - A study of 219 Asians. Int J Dermatol 41:748-753.
82. Tarlow JK, Clay FE, Cork MJ, Blakemore AI, McDonagh AJ, Messenger AG, Duff GW (1994) Severity of alopecia areata is associated with a polymorphism in the interleukin- 1 receptor antagonist gene. J Invest Dermatol 103:387-390.
83. Tazi-Ahnini R, Cork MJ, Gawkrodger DJ, Birch MP, Wengraf D, McDonagh AJ, Messenger AG (2002) Role of the autoimmune regulator (AIRE) gene in alopecia areata: Strong association of a potentially functional AIRE polymorphism with alopecia universalis. Tissue Antigens 60(6):489-495.
84. Tobin DJ (2003) Characterization of hair follicle antigens targeted by the anti-hair follicle immune response. J Investig Dermatol Symp Proc 8:176-181.
85. Tosti A, Iorizzo M, Botta GL, Milani M (2006) Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: A randomized, double-blind placebocontrolled trial. JEADV 20:1243-1247.
86. Tosti A, Piraccini BM, Pazzaglia M, Vincenzi C (2003) Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis J Am Acad Dermatol 49:96-98.
87. Valsecchi R, Vicari O, Frigeni A, Foiadelli L, Naldi L, Cainelli T (1985) Familial alopecia areata-genetic susceptibility or coincidence? Acta Derm Venereol 65:175-177.
88. Van der Steen P, Traupe H, Happle R, Boezeman J, Strater R, Hamm H (1992) The genetic risk for alopecia areata in first degree relatives of severely affected patients. Acta Derm Venereol (Stockh) 72:373-375.
89. Weise K, Kretzschmar L, John SM, Hamm H (1996) Topical immunotherapy in alopecia areata: Anamnestic and clinical criteria of prognostic significance. Dermatology 192:129-133.
90. Whiting DA (2003) Histopathologic features of alopecia areata: A new look. Arch Dermatol 139:1555-1559.
91. Wiseman MC, Shapiro J, MacDonald N, Lui H (2001) Predictive model for immunotherapy of alopecia areata with diphencyprone. Arch Dermatol 137:1063-1068.
92. Wunderlich C, Braun-Falco O (1965) Mongolismus und Alopecia areata. Med Welt 10:477-481.
93. Yang S, Yang J, Liu JB, Wang HY, Yang Q, Gao M, Liang YH, Lin GS, Lin D, Hu XL, Fan L, Zhang XJ (2004) The genetic epidemiology of alopecia areata in china. Br J Dermatol 151:16-23.
94. Zakaria W, Passeron T, Ostovari N, Lacour JP, Ortonne JP (2004) 308-nm excimer laser therapy in alopecia areata. J Am Acad Dermatol 51:837-838.
95. Zlotogorski A, Weinrauch L, Brautbar C (1990) Familial alopecia areata: no linkage with HLA. Tissue Antigens 36:40-41.
96. Zoller M, McElwee KJ, Engel P, Hoffmann R (2002) Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/HeJ mice with alopecia areata. J Invest Dermatol 118:983-992.